Novel substituted 2-methyl-3-indolylacetic derivatives were synthesized and evaluated for their activity in vitro and in vivo on COX-1 and COX-2. Active compounds were screened to determine their gastrointestinal tolerability in vivo in the rat. Results showed that 3 and 4 preferentially inhibited COX-1 in vitro and in vivo. MD simulations indicated an induced fit for COX-1 but not for COX-2, probably because of a lower plasticity of the latter.

Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage / Perissutti, Elisa; Fiorino, Ferdinando; C., Renner; Severino, Beatrice; Roviezzo, Fiorentina; Sautebin, Lidia; Rossi, Antonietta; Cirino, Giuseppe; Santagada, Vincenzo; Caliendo, Giuseppe. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - ELETTRONICO. - 49:26(2006), pp. 7774-7780. [10.1021/jm0608199]

Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage

PERISSUTTI, ELISA;FIORINO, FERDINANDO;SEVERINO, BEATRICE;ROVIEZZO, FIORENTINA;SAUTEBIN, LIDIA;ROSSI, ANTONIETTA;CIRINO, GIUSEPPE;SANTAGADA, VINCENZO;CALIENDO, GIUSEPPE
2006

Abstract

Novel substituted 2-methyl-3-indolylacetic derivatives were synthesized and evaluated for their activity in vitro and in vivo on COX-1 and COX-2. Active compounds were screened to determine their gastrointestinal tolerability in vivo in the rat. Results showed that 3 and 4 preferentially inhibited COX-1 in vitro and in vivo. MD simulations indicated an induced fit for COX-1 but not for COX-2, probably because of a lower plasticity of the latter.
2006
Synthesis of 2-Methyl-3-indolylacetic Derivatives as Anti-Inflammatory Agents That Inhibit Preferentially Cyclooxygenase 1 without Gastric Damage / Perissutti, Elisa; Fiorino, Ferdinando; C., Renner; Severino, Beatrice; Roviezzo, Fiorentina; Sautebin, Lidia; Rossi, Antonietta; Cirino, Giuseppe; Santagada, Vincenzo; Caliendo, Giuseppe. - In: JOURNAL OF MEDICINAL CHEMISTRY. - ISSN 0022-2623. - ELETTRONICO. - 49:26(2006), pp. 7774-7780. [10.1021/jm0608199]
File in questo prodotto:
File Dimensione Formato  
PERISSUTTI, 2006.pdf

accesso aperto

Tipologia: Documento in Post-print
Licenza: Accesso privato/ristretto
Dimensione 284.9 kB
Formato Adobe PDF
284.9 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/340938
Citazioni
  • ???jsp.display-item.citation.pmc??? 2
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 5
social impact